| Literature DB >> 35054293 |
Zenon Pogorelić1,2, Sachit Anand3, Tomislav Žuvela2, Apoorv Singh4, Zvonimir Križanac5, Nellai Krishnan4.
Abstract
BACKGROUND: The Coronavirus Disease 2019 (COVID-19) pandemic has impacted volume, management strategies and patient outcomes of acute appendicitis. The aim of this systematic review and meta-analysis was to evaluate whether the COVID-19 pandemic resulted in higher incidence of complicated appendicitis in children presenting with acute appendicitis compared to the pre-COVID-19 period. The secondary aim was to investigate the proportion of the patients treated by non-operative management (NOM).Entities:
Keywords: COVID-19; Coronavirus Disease 2019; acute appendicitis; appendectomy; children; non-operative management
Year: 2022 PMID: 35054293 PMCID: PMC8774400 DOI: 10.3390/diagnostics12010127
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418
Detailed search strategy.
| Database | Studies |
|---|---|
| PubMed | 66 |
| EMBASE | 102 |
| Web of science | 54 |
| SCOPUS | 123 |
| Total | 345 |
| Duplications | 180 |
| After duplication removal | 165 |
Figure 1Selection of the relevant studies using the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) flow diagram.
Baseline characteristics of the studies included in meta-analysis.
| Author | Study Design | Sample Size | Average (Mean/Median) | Average (Mean/Median) | |||
|---|---|---|---|---|---|---|---|
| A | B | A | B | A | B | ||
| Bonilla et al., 2020 [ | Retro | 49 | 41 | 40 (11–301) * | 30.5 (9–248) * | 5.3 (6.7) † | 4.2 (4.3) † |
| Fonseca et al., 2020 [ | Retro | 38 | 82 | 40.6 (35.5) † | 28.2 (23.2) † | 2.2 (2.0) † | 2.4 (2.6) † |
| La Pergola et al., 2020 [ | Retro | 86 | 92 | 1 (1–2) * days | 1 (1–2) * days | Not mentioned | |
| Place et al., 2020 [ | Cross | 90 | 70 | Not mentioned | Not mentioned | ||
| Schäfer et al., 2020 [ | Retro | 176 | 338 | Not mentioned | 5.3 (0.2) † | 4.9 (0.1) † | |
| Delgado-Miguel et al., 2021 [ | Retro | 31 | 26 | 46.8 (13.5) † | 22.9 (11.5) † | 4.9 (3.2) † | 2.5 (1.4) † |
| Esparaz et al., 2021 [ | Retro | 103 | 102 | Not mentioned | Not mentioned | ||
| Gerall et al., 2021 [ | Retro | 48 | 41 | 2 (0.5–14) * days | 1 (0.5–14) * days | 2 (0.5–22) * | 1 (0.5–9) * |
| Meyer et al., 2021 [ | Retro | 38 | 33 | 2 days * | 2 days * | 6 days * | 6 days * |
| Orthopoulos et al., 2021 [ | Retro | 37 | 96 | Not mentioned | 2.5 (3.1) † | 1.8 (1.9) † | |
| Percul et al., 2021 [ | Retro | 50 | 67 | 24 (3–120) * | 24 (4–96) * | 3 (2) † days | 3 (2) † days |
| Sheath et al., 2021 [ | Retro | 18 | 10 | 4 (1–14) * days | 2 (1–10) * days | 1 (0–10) * | 1 (0–6) * |
| Theodorou et al., 2021 [ | Retro | 592 | 606 | 2 (1–3) * days | 2 (1–3) * days | 3 (1–5) * | 2 (1–4) * |
† Mean (SD); * Median (range); Abbreviations: Retro—retrospective study; Cross—cross-sectional stud; A—group A (pandemic group); B—group B (pre-pandemic group); LOS—length of stay; Significant difference (p < 0.05) represented by shaded cells.
Downs and Black scale scores for the included studies by Observer 1 and Observer 2.
| Study | Reporting | External | Internal | Internal | Power | Total Scores |
|---|---|---|---|---|---|---|
| Methodological assessment by Observer 1 | ||||||
| Orthopoulos, 2021 [ | 9 | 3 | 5 | 2 | 0 | 19 |
| Bonilla, 2021 [ | 8 | 3 | 5 | 2 | 0 | 18 |
| Gerall, 2021 [ | 10 | 3 | 5 | 2 | 0 | 20 |
| Fonseca, 2020 [ | 10 | 3 | 5 | 2 | 0 | 20 |
| Sheath, 2021 [ | 9 | 3 | 5 | 2 | 0 | 19 |
| Place, 2020 [ | 8 | 3 | 5 | 2 | 0 | 18 |
| Percul, 2021 [ | 10 | 3 | 5 | 2 | 0 | 20 |
| Delgado-Miguel, 2021 [ | 9 | 3 | 5 | 2 | 0 | 19 |
| Meyer, 2021 [ | 8 | 3 | 5 | 2 | 0 | 18 |
| Esparaz, 2021 [ | 8 | 3 | 5 | 2 | 0 | 18 |
| Pergola, 2020 [ | 8 | 3 | 5 | 2 | 0 | 18 |
| Schafer, 2021 [ | 8 | 3 | 5 | 2 | 0 | 18 |
| Theodorou, 2021 [ | 11 | 3 | 5 | 2 | 4 | 25 |
| Methodological assessment by Observer 2 | ||||||
| Orthopoulos, 2021 [ | 10 | 3 | 5 | 2 | 0 | 20 |
| Bonilla, 2021 [ | 9 | 3 | 5 | 2 | 0 | 19 |
| Gerall, 2021 [ | 10 | 3 | 5 | 2 | 0 | 20 |
| Fonseca, 2020 [ | 9 | 3 | 5 | 2 | 0 | 19 |
| Sheath, 2021 [ | 9 | 3 | 5 | 2 | 0 | 19 |
| Place, 2020 [ | 7 | 3 | 5 | 2 | 0 | 17 |
| Percul, 2021 [ | 10 | 3 | 5 | 2 | 0 | 20 |
| Delgado-Miguel, 2021 [ | 10 | 3 | 5 | 2 | 0 | 20 |
| Meyer, 2021 [ | 8 | 3 | 5 | 2 | 0 | 18 |
| Esparaz, 2021 [ | 8 | 3 | 5 | 2 | 0 | 18 |
| Pergola, 2020 [ | 9 | 3 | 5 | 2 | 0 | 19 |
| Schafer, 2021 [ | 8 | 3 | 5 | 2 | 0 | 18 |
| Theodorou, 2021 [ | 11 | 3 | 5 | 2 | 4 | 25 |
The total scores and inter-observer agreement.
| Study | Rater 1 | Rater 2 | Mean | Kappa Value |
|
|---|---|---|---|---|---|
| Orthopoulos, 2021 [ | 19 | 20 | 19.5 | 0.961 | <0.001 |
| Bonilla, 2021 [ | 18 | 19 | 18.5 | ||
| Gerall, 2021 [ | 20 | 20 | 20 | ||
| Fonseca, 2020 [ | 20 | 19 | 19.5 | ||
| Sheath, 2021 [ | 19 | 19 | 19 | ||
| Place, 2020 [ | 18 | 17 | 17.5 | ||
| Percul, 2021 [ | 20 | 20 | 20 | ||
| Delgado-Miguel, 2021 [ | 19 | 20 | 19.5 | ||
| Meyer, 2021 [ | 18 | 18 | 18 | ||
| Esparaz, 2021 [ | 18 | 18 | 18 | ||
| Pergola, 2020 [ | 18 | 19 | 18.5 | ||
| Schafer, 2021 [ | 18 | 18 | 18 | ||
| Theodorou, 2021 [ | 25 | 25 | 25 |
Figure 2Forest plot comparison of the incidence of complicated appendicitis between the two groups of patients, i.e., presenting during the COVID-19 pandemic versus the pre-pandemic period. COVID—Coronavirus Disease 2019. M-H—Mantel–Haenszel method; CI—confidence interval.
Figure 3Forest plot comparison of the non-operative management (NOM) rates between the two groups of patients, i.e., presenting during the COVID-19 pandemic versus the pre-pandemic period. COVID—Coronavirus Disease 2019; M-H—Mantel–Haenszel method; CI—confidence interval.